Total Payments
$11,899
2024 Payments
$2,145
Companies
46
Transactions
524
Medicare Patients
1,487
Medicare Billing
$335,367
Payment Breakdown by Category
Food & Beverage$11,550 (97.1%)
Education$328.32 (2.8%)
Other$20.83 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,550 | 517 | 97.1% |
| Education | $328.32 | 6 | 2.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.83 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,687 | 75 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,530 | 55 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,420 | 62 | $0 (2024) |
| Insmed, Inc. | $810.37 | 31 | $0 (2024) |
| Genentech USA, Inc. | $676.91 | 47 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $629.34 | 37 | $0 (2024) |
| Electromed, Inc. | $511.42 | 20 | $0 (2022) |
| HARMONY BIOSCIENCES LLC | $499.61 | 17 | $0 (2024) |
| Shionogi Inc | $368.71 | 13 | $0 (2023) |
| INOGEN, INC. | $307.41 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,145 | 81 | GlaxoSmithKline, LLC. ($304.88) |
| 2023 | $2,259 | 93 | GlaxoSmithKline, LLC. ($498.05) |
| 2022 | $2,091 | 91 | GlaxoSmithKline, LLC. ($376.25) |
| 2021 | $1,222 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($238.45) |
| 2020 | $1,062 | 46 | Actelion Pharmaceuticals US, Inc. ($237.13) |
| 2019 | $1,224 | 62 | Actelion Pharmaceuticals US, Inc. ($175.56) |
| 2018 | $725.80 | 39 | Electromed, Inc. ($148.43) |
| 2017 | $1,171 | 56 | Actelion Pharmaceuticals US, Inc. ($278.50) |
All Payment Transactions
524 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $36.13 | General |
| Category: Medical Device | ||||||
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $38.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/06/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $30.21 | General |
| Category: Narcoplepsy | ||||||
| 11/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Education | Cash or cash equivalent | $89.99 | General |
| Category: Narcoplepsy | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $24.33 | General |
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 356 | 524 | $220,248 | $68,731 |
| 2022 | 7 | 366 | 592 | $256,070 | $84,949 |
| 2021 | 9 | 419 | 709 | $319,770 | $106,141 |
| 2020 | 8 | 346 | 504 | $232,414 | $75,547 |
Total Patients
1,487
Total Services
2,329
Medicare Billing
$335,367
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 128 | 217 | $136,781 | $42,348 | 31.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 114 | $39,122 | $12,378 | 31.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 88 | $19,981 | $6,360 | 31.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 21 | 28 | $8,904 | $2,778 | 31.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 33 | 38 | $5,461 | $1,753 | 32.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,597 | $1,436 | 31.2% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 14 | 15 | $3,833 | $1,186 | 30.9% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 11 | 12 | $1,569 | $491.64 | 31.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 134 | 280 | $182,932 | $61,006 | 33.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 46 | 68 | $22,167 | $7,621 | 34.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 65 | $19,531 | $6,103 | 31.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 74 | $15,502 | $4,989 | 32.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 42 | 55 | $6,371 | $2,082 | 32.7% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 21 | 25 | $6,410 | $2,076 | 32.4% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 19 | 25 | $3,158 | $1,071 | 33.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 155 | 357 | $235,232 | $77,804 | 33.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 65 | 89 | $29,521 | $9,880 | 33.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 74 | 108 | $22,810 | $7,797 | 34.2% |
| 36571 | Insertion of central venous catheter for infusion with port beneath the skin, patient 5 years or older | Facility | 2021 | 12 | 13 | $13,359 | $4,103 | 30.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 22 | 27 | $8,186 | $2,821 | 34.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 53 | 65 | $7,294 | $2,377 | 32.6% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 12 | 17 | $2,276 | $736.61 | 32.4% |
| 94375 | Respiratory diagnostic testing (flow volume loop) | Office | 2021 | 13 | 17 | $704.20 | $496.62 | 70.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 13 | 16 | $388.48 | $125.76 | 32.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 142 | 254 | $168,189 | $54,583 | 32.5% |
About Dr. Erum Zahid, MD
Dr. Erum Zahid, MD is a Pulmonary Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851571988.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erum Zahid, MD has received a total of $11,899 in payments from pharmaceutical and medical device companies, with $2,145 received in 2024. These payments were reported across 524 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($11,550).
As a Medicare-enrolled provider, Zahid has provided services to 1,487 Medicare beneficiaries, totaling 2,329 services with total Medicare billing of $335,367. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Brooklyn, NY
- Active Since 11/06/2007
- Last Updated 04/28/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1851571988
Products in Payments
- UPTRAVI (Drug) $955.68
- Arikayce (Drug) $794.13
- NUCALA (Biological) $651.21
- TRELEGY ELLIPTA (Drug) $607.06
- OFEV (Drug) $533.89
- SMARTVEST (Device) $511.42
- WAKIX (Drug) $499.61
- Xolair (Biological) $491.10
- Fetroja (Drug) $368.71
- ACTHAR (Biological) $353.45
- OPSUMIT MACITENTAN (Drug) $325.11
- TEZSPIRE (Biological) $269.79
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $266.01
- YUPELRI (Drug) $261.57
- OPSUMIT (Drug) $249.22
- AREXVY (Drug) $235.06
- PURIFIED CORTROPHIN GEL (Drug) $224.53
- ELIQUIS (Drug) $205.66
- FASENRA (Biological) $191.68
- Esbriet (Biological) $185.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Brooklyn
Dr. Chaim Bernstein, M.d, M.D
Pulmonary Disease — Payments: $254,754
Pulmonary Disease $254,754
Dr. Boris Sagalovich, Md, MD
Pulmonary Disease — Payments: $253,577
Pulmonary Disease $253,577
Dr. Maurice Alwaya, Md, MD
Pulmonary Disease — Payments: $22,286
Pulmonary Disease $22,286
Aron Rubin, Md, MD
Pulmonary Disease — Payments: $17,669
Pulmonary Disease $17,669
Elliott Bondi, Md, MD
Pulmonary Disease — Payments: $16,602
Pulmonary Disease $16,602
Dr. Mohammad Zaman, Md, MD
Pulmonary Disease — Payments: $12,861
Pulmonary Disease $12,861